Skip to main content
ArticleOPEN ACCESS

Erratum: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy (Allergy Asthma Clin Immunol (2020) 16: 25 DOI: 10.1186/s13223-020-00419-z)

Allergy, Asthma and Clinical Immunology
DOI: 10.1186/s13223-020-00435-z
0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The names of Tomas Eiwegger, Julia Upton, Gordon Sussman and Tomas Poder were inadvertently omitted from the authorship of the original article [1]. Tomas Eiwegger, Julia Upton, Gordon Sussman and Tomas Poder had participated in meetings and exchanges regarding the trial design and their names are added to recognise their contribution to the conception of the protocol.

Cite

CITATION STYLE

APA

Langlois, A., Lavergne, M. H., Leroux, H., Killer, K., Azzano, P., Paradis, L., … Bégin, P. (2020, May 20). Erratum: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy (Allergy Asthma Clin Immunol (2020) 16: 25 DOI: 10.1186/s13223-020-00419-z). Allergy, Asthma and Clinical Immunology. BioMed Central Ltd. https://doi.org/10.1186/s13223-020-00435-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free